Showing results (151-160 of 556) with videos related to

Sort By:
Pageof 56
Movement Disorders : Official Journal of the Movement Disorder Society|December 25, 2019
Dyskinesia mattersM Angela Cenci, Sara Riggare, Rajesh Pahwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2017
Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiersAntonio P Strafella, Nicolaas I Bohnen, Joel S Perlmutter, et al.
ACS Chemical Neuroscience|February 6, 2018
In Vivo Characterization of Two <sup>18</sup>F-Labeled PDE10A PET Radioligands in Nonhuman Primate BrainsHui Liu, Hongjun Jin, Zonghua Luo, et al.
European Journal of Pharmacology|October 10, 2021
In vitro characterization of [<sup>3</sup>H]VAT in cells, animal and human brain tissues for vesicular acetylcholine transporterQianwa Liang, Sumit Joshi, Hui Liu, et al.
Clinical Parkinsonism & Related Disorders|January 9, 2026
Differentiating effects of levodopa and subthalamic nucleus deep brain stimulation on motor features in Parkinson diseaseTiffanie A Lee, Deepa Ramesh, Mwiza Ushe, et al.
Brain Research. Cognitive Brain Research|July 23, 2004
Dopaminergic modulation of response inhibition: an fMRI studyTamara Hershey, Kevin J Black, Johanna Hartlein, et al.
Medchemcomm|January 14, 2015
Radiosynthesis and <i>in vivo</i> evaluation of a novel σ<sub>1</sub> selective PET ligandHongjun Jin, Jinda Fan, Xiang Zhang, et al.
Neurobiology of Disease|June 5, 2007
Normal platelet mitochondrial complex I activity in Huntington's diseaseWilliam J Powers, Richard H Haas, Thuy Le, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2010
Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?Morvarid Karimi, Stephen M Moerlein, Tom O Videen, et al.
Pageof 56